O'Riordan, Michael. (April 1, 2016) ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors. TCTMD. Available online at http://www.tctmd.com/show.aspx?id=134620. Accessed April 17, 2016.
Herman, Amy. (April 4, 2016) Heart Groups Issue Guidelines on Non-Statin Therapies for LDL-Lowering. NEJM Journal Watch. Available online at http://www.jwatch.org/fw111390/2016/04/04/heart-groups-issue-guidelines-non-statin-therapies-ldl?query=pfwRSTOC&jwd=000020042125&jspc. Accessed April 17, 2016.
Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly Jr DD, DePalma SM, Minissian MB, Orringer CE, Smith SC. 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2016. Available as pdf at http://content.onlinejacc.org/article.aspx?articleID=2510936#tab1. Accessed April 17, 2016.